Abstract
The AMV v-Myb oncoprotein causes oncogenic transformation of myelomonocytic cells in vivo and in vitro. Its transforming capacity is strictly dependent upon the N-terminal DNA binding domain, the central transactivation region, and on the C-terminal domain containing a putative leucine zipper motif. Here we show that the v-MybL3,4A mutant, in which Leu325 and Leu332 of the leucine zipper have been replaced by alanines, failed to induce leukemia in virus infected chicken. This demonstrates that the leucine zipper domain is indispensable for v-myb induced leukemogenesis in vivo. v-MybL3,4A was, however, still able to transform myelomonocytic cells from chicken bone marrow in vitro. Yet, while v-mybL3,4A transformed cells were impaired in growth at 37°C, they failed to grow at 42°C, the physiological body temperature of avian species. This might explain the loss of v-MybL3,4A leukemogenic potential in vivo. We also demonstrate that the v-Myb leucine zipper domain interacts in vitro with two host cell proteins, p26 and p28. This interaction is compromised in v-MybL3,4A indicating that binding of v-Myb to p26 and p28 might be important for the leukemogenic potential of v-Myb.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartůněk, P., Karafiát, V., Dvořáková, M. et al. The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein. Oncogene 15, 2939–2949 (1997). https://doi.org/10.1038/sj.onc.1201457
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201457
Keywords
This article is cited by
-
DNA released by leukemic cells contributes to the disruption of the bone marrow microenvironment
Oncogene (2013)
-
GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter
Oncogene (2003)
-
Mutational analysis of the transcriptional activation domains of v-Myb
Oncogene (2002)
-
The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferation
Oncogene (1999)
-
Transformation by v-Myb
Oncogene (1999)